Key facts
| Price (PPV) | 70 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | irbesartanhydrchlorothiazide |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09DA04 |
| Manufacturer | SOTHEMA |
| Presentation | Boite de 14 |
| Nature | Médicament |
| Hospital price | 43.70 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement de l'hypertension artérielle essentielle lorsque l'effet d'une monothérapie reste insuffisant. Traitement initial en cas d'hypertension prononcée, lorsqu'un contrôle rapide de la pression artérielle (en termes de jours ou de semaines) est de première importance clinique.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
In Morocco, 9 other products contain the same active substance as Co-Avepro 150 mg / 12.5 mg (Irbesartan | Hydrchlorothiazide), at the same strength and in the same dosage form. For the same pack size (Boite de 14), the cheapest is Co-Icard 150 mg / 12.5 mg (COOPER PHARMA) at 69.50 MAD, i.e. 1 % less than Co-Avepro 150 mg / 12.5 mg (70 MAD). The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Co-Icard 150 mg / 12.5 mg | COOPER PHARMA | Boite de 14 | 69.50 MAD | 4.96 / unit | −1 % |
| Co-Irvel 150 mg / 12.5 mg | AFRIC-PHAR | Boite de 14 | 69.50 MAD | 4.96 / unit | −1 % |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Co-Arapro 150 mg / 12.5 mg | ZENITH PHARMA | Boite de 10 | 50.30 MAD | 5.03 / unit |
| Co-Icard 150 mg / 12.5 mg | COOPER PHARMA | Boite de 28 | 124 MAD | 4.43 / unit |
| Co-Irvel 150 mg / 12.5 mg | AFRIC-PHAR | Boite de 28 | 124 MAD | 4.43 / unit |
| Co-Arapro 150 mg / 12.5 mg | ZENITH PHARMA | Boite de 30 | 129.80 MAD | 4.33 / unit |
| Coavacor 150 mg / 12.5 mg | POLYMEDIC | Boite de 30 | 129.80 MAD | 4.33 / unit |
| Irphi Plus 150 mg / 12.5 mg | PHI | Boite de 30 | 129.80 MAD | 4.33 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Co-Avepro 150 mg / 12.5 mg
Co-Avepro 150 mg / 12.5 mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by SOTHEMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Co-Avepro 150 mg / 12.5 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Co-Avepro 150 mg / 12.5 mg
Answers to common questions from Moroccan patients about this drug.